Invasive Prenatal Testing gains momentum through advanced genomics, safer early screening, healthcare investment, and wider access to genetic testing.Dublin, Oct. 15, 2026 (GLOBE NEWSWIRE) -- "Saudi ...
A new case report describes how chromosomal microarray and trio whole-exome sequencing revealed a 10.42 Mb homozygous segment ...
Recurring services and consumables, centralized high-throughput labs, automation, payer connectivity and outsourced testing support scale, efficiency and sustainable returns.Dublin, Oct. 16, 2026 ...
AAP Newsroom on MSN
Prenatal screening company makes strong debut on ASX
Indentifai Genetics, an Israeli company seeking to commercialise an AI-powered prenatal test, has successfully listed on ...
A new case report and pooled analysis of 35 prenatal cases shows that 15q duplication syndrome frequently escapes prenatal ...
Identifai Genetics (ASX:IDG) is heading for an ASX listing with a US$2.2m loss, a US$1m cash balance, and a prenatal test ...
"Should I get NIPT?" and "How exactly is it different from amniocentesis?"—consultations regarding prenatal diagnosis are ...
This week’s Bulls N’ Bears ASX Runner of the Week is… Identifai, after the Israeli biotech newcomer made a stellar debut on the ASX with its AI-powered prenatal screening technology.
Evidence highlights the challenges of non-RhD alloimmunization and the limitations of cell-free DNA testing for fetal antigen ...
Rajdeep Panwar, Chief Commercial Officer, Thyrocare Technologies discusses key consumer trends shaping the diagnostics sector ...
Identifai Genetics Ltd (ASX:ID1) has started trading on the Australian Securities Exchange (ASX) today following a $10 million initial public offering (IPO), with funds earmarked to advance clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results